Design Features of Nonclinical Studies of In Vivo Gene Therapy Medicinal Products. Part 1: Pharmacological studies
Open Access
- 29 November 2025
- journal article
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 10 (4) , 113-120
Abstract
Особенности дизайна доклинических исследований препаратов генной терапии in vivo. Часть 1: фармакологические исследованияKeywords
This publication has 7 references indexed in Scilit:
- Gene Therapy Medicinal Products: Non-clinical Safety StudiesSafety and Risk of Pharmacotherapy, 2023
- Regulatory Consideration for the Nonclinical Safety Assessment of Gene TherapiesHuman Gene Therapy, 2022
- Systemic and local immune responses to intraocular AAV vector administration in non-human primatesMolecular Therapy - Methods & Clinical Development, 2022
- Optimising the IgG‐degrading enzyme treatment regimen for enhanced adeno‐associated virus transduction in the presence of neutralising antibodiesClinical & Translational Immunology, 2022
- Advanced Therapy Medicines Based on Oncolytic Viruses (Part I: Development and Authorisation of Products in China)Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation, 2021
- World practice of providing scientific advice on the development and authorisation of innovative medicinesBiological Products. Prevention, Diagnosis, Treatment, 2021
- Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) modelsAdvanced Drug Delivery Reviews, 2021